Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 328 (5986): 1641-1642

Copyright © 2010 by the American Association for the Advancement of Science

Medicine

Tackling Two Diseases with HDL

Göran K. Hansson, and Magnus Björkholm

High-density lipoproteins (HDLs) transport cholesterol from peripheral tissues to the liver, helping to protect against diseases such as atherosclerosis. On page 1689 in this issue, Yvan-Charvet et al. present an entirely new role for HDL in regulating stem cell proliferation in the bone marrow (1). A relationship between cellular cholesterol content, HDL, and cells of the myelomonocytic lineage opens up the possibility that disorders characterized by the proliferation of immature white blood cells could be treated by targeting cholesterol transport in these cells.

Center for Molecular Medicine and Department of Medicine, Karolinska Institutet, SE-17176 Stockholm, Sweden.

E-mail: goran.hansson{at}ki.se

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders.
E. L. Gautier, M. Westerterp, N. Bhagwat, S. Cremers, A. Shih, O. Abdel-Wahab, D. Lutjohann, G. J. Randolph, R. L. Levine, A. R. Tall, et al. (2013)
J. Exp. Med. 210, 339-353
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882